+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Transcatheter Embolization and Occlusion Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026

  • ID: 4851171
  • Report
  • December 2018
  • Region: Global
  • 231 pages
  • Transparency Market Research
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now

Transcatheter Embolization and Occlusion Devices Market - Overview

The global transcatheter embolization and occlusion devices market is growing at a rapid pace due to increase in advancements in treating complex diseases. Transcatheter embolization and occlusion devices have wide range of applications in the medical field. The embolization particles segment is anticipated to expand at a high CAGR during the forecast period. Rise in demand for drug-eluting beads and radioembolization particles contribute to the growth of the embolization particles segment. Increase in incidence of chronic diseases drives demand for products that offer rapid and efficient healing. Hence, a majority of hospitals have shifted preference toward advanced products. This helps decrease the average length of stay in hospitals through early recovery from disease. This, in turn, helps reduce surgical costs. Therefore, rise in need and demand for advanced products that increase therapeutic outcome drives the global transcatheter embolization and occlusion devices market.

The global transcatheter embolization and occlusion devices market has been analyzed based on product, application, end-user, and region. In terms of product, the market has been classified into embolization coils, coiling-assist devices, embolization particles, flow diverter devices, liquid embolics, and accessories. The embolization coils segment has been bifurcated into pushable and detachable. The coiling-assist devices segment has been segregated into stent-assisted coiling and balloon-assisted coiling. The embolization particles segment has been categorized into radioembolization particles, microspheres, drug-eluting beads, and others. The accessories segment has been divided into catheters, guide wires, and others. Based on application, the global transcatheter embolization and occlusion devices market has been classified into peripheral vascular disease, neurology, oncology, urology, and others. In terms of end-user, the market has been divided into hospitals, ambulatory surgical centers, and clinics. Each of the segments has been analyzed in detail in terms of market trends, recent developments, outlook, and opportunities. The report provides current and future market size for each segment and sub-segment for the period from 2018 to 2026, in terms of revenue in US$ Mn, considering 2016 and 2017 as the base years. The compound annual growth rate (% CAGR) for each market segment has been provided for the forecast period from 2018 to 2026 along with the estimations of market size.

In terms of region, the global transcatheter embolization and occlusion devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have also been sub-segmented into major countries and sub-regions. The current and future market sizes in terms of revenue (US$ Mn) of these regional markets and their major countries/sub-regions have been provided in the report for the period from 2016 to 2026, with CAGR (%) for the period from 2018 to 2026. The study also offers a list of recommendations and highlights of the market for new companies willing to enter the market and for existing companies to increase market shares, which is likely to help in the decision-making process.

The overview section of the report provides the market dynamics and market trends such as drivers, restraints, opportunities, and key trends that influence the current and future status of the transcatheter embolization and occlusion devices market. The report also covers market attractiveness and market share analyses in order to provide a thorough analysis of the overall competitive scenario in the global transcatheter embolization and occlusion devices market.

The report concludes with the company profiles section that includes information about the major players in the market. Key players profiled in the report include BTG plc, Boston Scientific Corporation, Medtronic plc, Penumbra, Inc., Cook Medical, Edwards Lifesciences Corporation, Merit Medical Systems, Johnson & Johnson Services, Inc., Pfizer, Inc., Stryker Corporation, Terumo Corporation, Sirtex Medical Limited, and Abbott Laboratories. Each of these players has been profiled in the report considering parameters such as company overview, financial overview, business strategies, product portfolio, and recent developments.

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Transcatheter Embolization and Occlusion Devices Market

4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Transcatheter Embolization and Occlusion Devices Market Analysis and Forecasts, 2016-2026
4.4.1. Market Revenue Projections (US$ Mn) and Volume Projections (Units)
4.5. Value Chain Analysis

5. Market Outlook

6. Global Transcatheter Embolization and Occlusion Devices Market Analysis and Forecasts, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value and Volume Forecast, by Product, 2016-2026
6.3.1. Embolization Coils
6.3.1.1. Pushable
6.3.1.2. Detachable
6.3.2. Coiling-assist Devices
6.3.2.1. Stent-assisted Coiling
6.3.2.2. Balloon-assisted Coiling
6.3.3. Embolization Particles
6.3.3.1. Radioembolization Particles
6.3.3.2. Microspheres
6.3.3.3. Drug-eluting Beads
6.3.3.4. Others
6.3.4. Flow Diverter Devices
6.3.5. Liquid Embolics
6.3.6. Accessories
6.3.6.1. Catheters
6.3.6.2. Guide wires
6.3.6.3. Others
6.4. Market Attractiveness, by Product

7. Global Transcatheter Embolization and Occlusion Devices Market Analysis and Forecasts, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2016-2026
7.3.1. Peripheral Vascular Disease
7.3.2. Neurology
7.3.3. Oncology
7.3.4. Urology
7.3.5. Others
7.4. Market Attractiveness, by Application

8. Global Transcatheter Embolization and Occlusion Devices Market Analysis and Forecasts, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2016-2026
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Clinics
8.4. Market Attractiveness, by End-user

9. Global Transcatheter Embolization and Occlusion Devices Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Market Value and Volume Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region

10. North America Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value and Volume Forecast By Product, 2016-2026
10.2.1. Embolization Coils
10.2.1.1. Pushable
10.2.1.2. Detachable
10.2.2. Coiling-assist Devices
10.2.2.1. Stent-assisted Coiling
10.2.2.2. Balloon-assisted Coiling
10.2.3. Embolization Particles
10.2.3.1. Radioembolization Particles
10.2.3.2. Microspheres
10.2.3.3. Drug-eluting Beads
10.2.3.4. Others
10.2.4. Flow Diverter Devices
10.2.5. Liquid Embolics
10.2.6. Accessories
10.2.6.1. Catheters
10.2.6.2. Guide wires
10.2.6.3. Others
10.3. Market Value Forecast, by Application, 2016-2026
10.3.1. Peripheral Vascular Disease
10.3.2. Neurology
10.3.3. Oncology
10.3.4. Urology
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2016-2026
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Clinics
10.5. Market Value and Volume Forecast, by Country, 2016-2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country

11. Europe Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value and Volume Forecast, by Product, 2016-2026
11.2.1. Embolization Coils
11.2.1.1. Pushable
11.2.1.2. Detachable
11.2.2. Coiling-assist Devices
11.2.2.1. Stent-assisted Coiling
11.2.2.2. Balloon-assisted Coiling
11.2.3. Embolization Particles
11.2.3.1. Radioembolization Particles
11.2.3.2. Microspheres
11.2.3.3. Drug-eluting Beads
11.2.3.4. Others
11.2.4. Flow Diverter Devices
11.2.5. Liquid Embolics
11.2.6. Accessories
11.2.6.1. Catheters
11.2.6.2. Guide wires
11.2.6.3. Others
11.3.Market Value Forecast, by Application, 2016-2026
11.3.1. Peripheral Vascular Disease
11.3.2. Neurology
11.3.3. Oncology
11.3.4. Urology
11.3.5. Others
11.4.Market Value Forecast, by End-user, 2016-2026
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Clinics
11.5.Market Value and Volume Forecast, by Country/Sub-region, 2016-2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. Rest of Europe
11.6.Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region

12. Asia Pacific Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value and Volume Forecast, by Product, 2016-2026
12.2.1. Embolization Coils
12.2.1.1. Pushable
12.2.1.2. Detachable
12.2.2. Coiling-assist Devices
12.2.2.1. Stent-assisted Coiling
12.2.2.2. Balloon-assisted Coiling
12.2.3. Embolization Particles
12.2.3.1. Radioembolization Particles
12.2.3.2. Microspheres
12.2.3.3. Drug-eluting Beads
12.2.3.4. Others
12.2.4. Flow Diverter Devices
12.2.5. Liquid Embolics
12.2.6. Accessories
12.2.6.1. Catheters
12.2.6.2. Guide wires
12.2.6.3. Others
12.3.Market Value Forecast, by Application, 2016-2026
12.3.1. Peripheral Vascular Disease
12.3.2. Neurology
12.3.3. Oncology
12.3.4. Urology
12.3.5. Others
12.4.Market Value Forecast, by End-user, 2016-2026
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Clinics
12.5.Market Value and Volume Forecast, by Country/Sub-region, 2016-2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia
12.5.5. Rest of Asia Pacific
12.6.Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region

13. Latin America Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value and Volume Forecast, by Product, 2016-2026
13.2.1. Embolization Coils
13.2.1.1. Pushable
13.2.1.2. Detachable
13.2.2. Coiling-assist Devices
13.2.2.1. Stent-assisted Coiling
13.2.2.2. Balloon-assisted Coiling
13.2.3. Embolization Particles
13.2.3.1. Radioembolization Particles
13.2.3.2. Microspheres
13.2.3.3. Drug-eluting Beads
13.2.3.4. Others
13.2.4. Flow Diverter Devices
13.2.5. Liquid Embolics
13.2.6. Accessories
13.2.6.1. Catheters
13.2.6.2. Guide wires
13.2.6.3. Others
13.3.Market Value Forecast, by Application, 2016-2026
13.3.1. Peripheral Vascular Disease
13.3.2. Neurology
13.3.3. Oncology
13.3.4. Urology
13.3.5. Others
13.4.Market Value Forecast, by End-user, 2016-2026
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Clinics
13.5.Market Value and Volume Forecast, by Country/Sub-region, 2016-2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6.Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region

14. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2.Market Value and Volume Forecast, by Product, 2016-2026
14.2.1. Embolization Coils
14.2.1.1. Pushable
14.2.1.2. Detachable
14.2.2. Coiling-assist Devices
14.2.2.1. Stent-assisted Coiling
14.2.2.2. Balloon-assisted Coiling
14.2.3. Embolization Particles
14.2.3.1. Radioembolization Particles
14.2.3.2. Microspheres
14.2.3.3. Drug-eluting Beads
14.2.3.4. Others
14.2.4. Flow Diverter Devices
14.2.5. Liquid Embolics
14.2.6. Accessories
14.2.6.1. Catheters
14.2.6.2. Guide wires
14.2.6.3. Others
14.3.Market Value Forecast, by Application, 2016-2026
14.3.1. Peripheral Vascular Disease
14.3.2. Neurology
14.3.3. Oncology
14.3.4. Urology
14.3.5. Others
14.4.Market Value Forecast, by End-user, 2016-2026
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Clinics
14.5.Market Value and Volume Forecast, by Country/Sub-region, 2016-2026
14.5.1. UAE
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6.Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region

15. Competition Landscape
15.1. Competitive Market Ranking (2017)
15.2. Company Profiles
15.2.1. BTG plc
15.2.2. Boston Scientific Corporation
15.2.3. Medtronic plc
15.2.4. Penumbra, Inc.
15.2.5. Cook Medical
15.2.6. Edwards Lifesciences Corporation
15.2.7. Merit Medical Systems
15.2.8. Johnson & Johnson Services, Inc.
15.2.9. Pfizer, Inc.
15.2.10. Stryker Corporation
15.2.11. Terumo Corporation
15.2.12. Sirtex Medical Limited
15.2.13. Abbott Laboratories
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll